Trevi Therapeutics (TRVI) Stock Insights

TRVI price $13.52 +0.17 +1.27%

Ticker
TRVI
Price
$13.52
Change
+0.17 +1.27%
Market cap ?
$1.93B
P/E ?
-37.33
Dividend yield ?
0.00%
Beta ?
0.98
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
67
Value
53
Quality
47
Growth
100

Stocklytics score rationale: value 53, quality 47, growth 100.

Financials

2016201720182019202020212022202320242025
0000000000

Trevi Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the advancement and commercialization of Haduvio, a potential treatment for debilitating neurologically mediated conditions. This orally administered, extended-release formulation of nalbuphine is currently undergoing Phase IIb/III clinical trials for chronic pruritus (severe itching) and persistent cough experienced by patients with…

Fair value

TRVI fair value Not meaningful. Price $13.52.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Not meaningful

Compare TRVI

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-12—-0.13——
2026-08-06-0.11-0.11——
2026-05-05-0.09-0.07——
2026-03-17-0.06-0.10——
2025-11-13-0.08-0.10——
2025-08-07-0.09-0.10——
2025-05-08-0.09-0.13——
2025-03-18-0.11-0.12——
2024-11-06-0.13-0.12——
2024-08-08-0.12-0.11——
2024-05-07-0.11-0.09——
2024-03-20-0.08-0.10176.00K—
2023-11-09-0.08-0.09——
2023-08-10-0.07-0.09——
2023-05-11-0.06-0.08——
2023-03-16-0.06-0.11——
2022-11-10-0.12-0.15——
2022-08-11-0.14-0.21——
2022-05-12-0.24-0.31——
2022-03-17-0.28-0.34——
2021-11-10-0.34-0.33——
2021-08-12-0.49-0.46——
2021-05-13-0.43-0.49——
2021-03-25-0.52-0.45——
2020-11-12-0.41-0.59——
2020-08-13-0.41-0.52——
2020-05-07-0.48-0.44——
2020-03-16-0.19-0.51——
2019-11-14-0.41-0.48——
2019-08-12-0.63-0.41——
2019-06-13-13.85-0.52——
2019-05-08-0.34———
2018-09-30-0.63———
2018-06-30-0.54———
2018-03-31-0.45———
2017-12-31-8.05———

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-09-15Heffernan Michael ThomasBuy21.05K$3.3370.10K
2026-09-15Heffernan Michael ThomasBuy18.42K$3.0456.00K
2026-09-15Heffernan Michael ThomasSell20.95K$15.09316.17K
2026-09-15Heffernan Michael ThomasSell100$15.881.59K
2026-09-15Heffernan Michael ThomasSell18.42K$3.0456.00K
2026-09-15Heffernan Michael ThomasSell21.05K$3.3370.10K
2026-06-03Mathers Edward TBuy35.00K$13.45470.75K
2026-06-03Colangelo DominickBuy35.00K$13.45470.75K
2026-06-03Meeker David PBuy35.00K$13.45470.75K
2026-06-03VANLENT ANNEBuy35.00K$13.45470.75K
2026-06-03Heffernan Michael ThomasBuy35.00K$13.45470.75K
2026-02-19Cassella James VBuy215.00K$10.562.27M
2026-02-19Galletta ChristopherBuy35.00K$10.56369.60K
2026-02-19SCIASCIA THOMASBuy85.00K$10.56897.60K
2026-02-19GOOD JENNIFER LBuy675.00K$10.567.13M
2026-02-19Simon FarrellBuy160.00K$10.561.69M
2026-01-08HASTINGS DAVID CBuy375.00K$11.214.20M
2026-01-08HASTINGS DAVID COther0——
2025-12-31Florence Anthony A. Jr.Other0——
2025-12-31SANDELL SCOTT DOther0——
2025-12-31Behbahani AliOther0——
2025-12-31Makhzoumi MohamadOther0——
2025-12-31Walker Paul EdwardOther0——
2025-12-31Chang CarmenOther0——
2025-12-02Galletta ChristopherBuy4.22K$0.512.16K
2025-12-02Galletta ChristopherSell4.22K$0.512.16K
2025-06-11Mathers Edward TBuy45.00K$6.25281.25K
2025-06-11Colangelo DominickBuy45.00K$6.25281.25K
2025-06-11Heffernan Michael ThomasBuy45.00K$6.25281.25K
2025-06-11VANLENT ANNEBuy45.00K$6.25281.25K
2025-06-11Meeker David PBuy45.00K$6.25281.25K
2025-05-31Galletta ChristopherBuy8.55K$2.3820.35K
2025-05-31SCIASCIA THOMASBuy60.00K$2.38142.80K
2025-05-31Delfini LisaBuy72.00K$2.38171.36K
2025-05-31Simon FarrellBuy72.00K$2.38171.36K
2025-05-31GOOD JENNIFER LBuy102.00K$2.38242.76K
2025-04-17SANDELL SCOTT DBuy1.85M$1.372.54M
2025-04-17Florence Anthony A. Jr.Buy1.85M$1.372.54M
2025-04-17SANDELL SCOTT DSell1.85M$1.372.54M
2025-04-17Florence Anthony A. Jr.Sell1.85M$1.372.54M
2025-04-17Behbahani AliBuy1.85M$1.372.54M
2025-04-17Behbahani AliSell1.85M$1.372.54M
2025-04-17BASKETT FORESTBuy1.85M$1.372.54M
2025-04-17BASKETT FORESTSell1.85M$1.372.54M
2025-04-17Makhzoumi MohamadBuy1.85M$1.372.54M
2025-04-17Makhzoumi MohamadSell1.85M$1.372.54M
2025-04-17Walker Paul EdwardBuy1.85M$1.372.54M
2025-04-17Walker Paul EdwardSell1.85M$1.372.54M
2025-04-17New Enterprise Associates 16, L.P.Buy1.85M$1.372.54M
2025-04-17New Enterprise Associates 16, L.P.Sell1.85M$1.372.54M
2025-04-17Chang CarmenBuy1.85M$1.372.54M
2025-04-17Chang CarmenSell1.85M$1.372.54M
2025-03-25SCIASCIA THOMASBuy2.63K$1.433.76K
2025-03-25SCIASCIA THOMASSell2.63K$6.6017.36K
2025-03-25SCIASCIA THOMASSell2.63K$1.433.76K
2025-03-21GOOD JENNIFER LBuy5.26K$1.437.53K
2025-03-21GOOD JENNIFER LSell5.26K$6.5834.62K
2025-03-21GOOD JENNIFER LSell5.26K$1.437.53K
2025-03-10GOOD JENNIFER LBuy54.40K$2.38129.47K
2025-03-10Delfini LisaBuy38.40K$2.3891.39K
2025-03-10SCIASCIA THOMASBuy32.00K$2.3876.16K
2025-03-10Galletta ChristopherBuy4.56K$2.3810.85K
2025-03-10Simon FarrellBuy31.25K$0.5115.97K
2025-03-10Simon FarrellBuy63.81K$3.91249.51K
2025-03-10Simon FarrellSell76.96K$6.73517.78K
2025-03-10Simon FarrellSell4.35K$7.1531.10K
2025-03-10Simon FarrellBuy17.50K$3.2156.17K
2025-03-10Simon FarrellBuy38.40K$2.3891.39K
2025-03-10Simon FarrellSell31.25K$0.5115.97K
2025-03-10Simon FarrellSell63.81K$3.91249.51K
2025-03-10Simon FarrellSell17.50K$3.2156.17K
2025-02-18SCIASCIA THOMASBuy116.00K$4.22489.52K
2025-02-18Cassella James VBuy257.50K$4.221.09M
2025-02-18Simon FarrellBuy225.50K$4.22951.61K
2025-02-18Delfini LisaBuy225.50K$4.22951.61K
2025-02-18GOOD JENNIFER LBuy811.00K$4.223.42M
2025-02-18Galletta ChristopherBuy41.00K$4.22173.02K
2025-01-08Delfini LisaBuy5.00K$0.512.56K
2025-01-08Delfini LisaSell5.00K$0.512.56K
2025-01-07Delfini LisaBuy1.00K$0.51511
2025-01-07Delfini LisaSell1.00K$0.51511
2024-12-13Galletta ChristopherSell15.00K$0.517.67K
2024-12-13Galletta ChristopherBuy15.00K$0.517.67K
2024-09-30Cassella James VBuy400.00K$3.341.34M
2024-09-09GOOD JENNIFER LBuy1.84K$1.432.63K
2024-09-09GOOD JENNIFER LSell1.84K$3.045.59K
2024-09-09GOOD JENNIFER LSell1.84K$1.432.63K
2024-09-06GOOD JENNIFER LBuy4.22K$1.436.03K
2024-09-06GOOD JENNIFER LSell4.22K$3.0312.78K
2024-09-06GOOD JENNIFER LSell4.22K$1.436.03K
2024-09-05GOOD JENNIFER LBuy40.28K$1.4357.60K
2024-09-05GOOD JENNIFER LSell40.28K$3.11125.31K
2024-09-05GOOD JENNIFER LSell40.28K$1.4357.60K
2024-09-04GOOD JENNIFER LBuy10.98K$1.4315.70K
2024-09-04GOOD JENNIFER LSell10.98K$3.0233.21K
2024-09-04GOOD JENNIFER LSell10.98K$1.4315.70K
2024-09-03GOOD JENNIFER LBuy3.86K$1.435.52K
2024-09-03GOOD JENNIFER LSell3.86K$3.0211.68K
2024-09-03GOOD JENNIFER LSell3.86K$1.435.52K
2024-08-27Meeker David PBuy4.55K$1.436.51K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 226, holders +21 vs prior quarter. Ownership 95.79%.

HolderSharesChangeChange %Value
NEA MANAGEMENT COMPANY, LLC13.22M00.00%246.59M
FMR LLC12.56M4.52M+56.29%234.30M
BLACKROCK, INC.11.16M914.84K+8.93%208.04M
FRAZIER LIFE SCIENCES MANAGEMENT, L.P.9.94M-100-0.00%185.37M
WELLINGTON MANAGEMENT GROUP LLP5.68M495.50K+9.55%106.02M
VANGUARD CAPITAL MANAGEMENT LLC5.53M552.11K+11.09%103.15M
VIVO CAPITAL, LLC5.09M00.00%95.02M
WOODLINE PARTNERS LP4.08M3.08M+307.81%76.12M
VESTAL POINT CAPITAL, LP3.10M933.50K+43.09%57.81M
MPM BIOIMPACT LLC3.07M-224.85K-6.82%57.32M
FRONTIER CAPITAL MANAGEMENT CO LLC3.07M1.08M+53.98%57.27M
STATE STREET CORP3.03M362.00K+13.58%56.46M
GEODE CAPITAL MANAGEMENT, LLC2.93M149.84K+5.39%54.62M
MARSHALL WACE, LLP2.67M-1.29M-32.57%49.87M
EVENTIDE ASSET MANAGEMENT, LLC2.66M37.69K+1.44%49.61M
RUBRIC CAPITAL MANAGEMENT LP2.50M-1.21M-32.54%46.71M
ARTIA GLOBAL PARTNERS LP2.21M197.25K+9.80%41.23M
ACORN CAPITAL ADVISORS, LLC2.14M00.00%40.00M
FIRST LIGHT ASSET MANAGEMENT, LLC2.10M2.10MNew39.11M
PICTET ASSET MANAGEMENT HOLDING SA2.01M307.74K+18.04%37.56M
LOGOS GLOBAL MANAGEMENT LP1.88M-520.00K-21.67%35.06M
AFFINITY ASSET ADVISORS, LLC1.80M-200.00K-10.00%33.57M
EMERALD ADVISERS, LLC1.80M-41.95K-2.28%33.53M
SIREN, L.L.C.1.79M00.00%33.33M
PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC1.74M188.95K+12.16%32.50M

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Trevi Therapeutics (TRVI) Stock Insights

TRVI$13.52+0.17 +1.27%

$1.93B

Market Cap

-37.33

P/E

—

Forward P/E

67

Score

Price History